Get started
Author

Joanna Vermeij

Observed names: J Vermeij, J. Vermeij, Joanna M. Vermeij, Vermeij, J, Vermeij, Joanna
Observed institutions: Ontario Institute for Cancer Research, European Organisation for Research and Treatment of Cancer, Cheltenham General Hospital, University Medical Center Groningen, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Vrije Universiteit Brussel, Lund University, University of Washington, Beatson West of Scotland Cancer Centre, Sahlgrenska University Hospital, Institut Jules Bordet, Erasmus MC, Breast International Group, ZNA Middelheim Hospital, European Organisation for Research and Treatment of Cancer, Swiss Group For Clinical Cancer Research, Ziekenhuisnetwerk Antwerpen Stuivenberg, Ziekenhuis aan de Stroom, University of Edinburgh
ORCID: 0000-0003-0041-6957
Observed ORCID: 0000-0003-0041-6957
OpenAlex ID: A5016466918
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
2017 · F. Cardoso, J.M.S. Bartlett, et al. · Annals of Oncology · 405
PDF
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
2017 · Marco Colleoni, Weixiu Luo, et al. · The Lancet Oncology · 122
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
2018 · Christian Rolfo, Paolo Manca, et al. · ESMO Open · 102
PDF
Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers
2008 · Joanna Vermeij, Erik Teugels, et al. · BMC Cancer · 68
PDF
Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.
1996 · B Neyns, Katesuwanasing, et al. · PubMed · 49
Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program
2015 · Fatima Cardoso, John Bartlett, et al. · Cancer Research · 26
Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
2006 · Bart Neyns, Yves Van Nieuwenhove, et al. · PubMed · 22
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)
2016 · Jacques De Grève, Jan Van Meerbeeck, et al. · PLoS ONE · 20
PDF
Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector
2001 · J Vermeij, Z Zeinoun, et al. · British Journal of Cancer · 16
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
2022 · J. Thouvenin, C. Van Marcke, et al. · ESMO Open · 14
PDF
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program
2016 · Charles Van Praet, Sylvie Rottey, et al. · Urologic Oncology Seminars and Original Investigations · 13
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
2021 · Jane Bayani, Coralie Poncet, et al. · npj Breast Cancer · 10
PDF
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
2017 · Charles Van Praet, Sylvie Rottey, et al. · Clinical Genitourinary Cancer · 10
[Targeted therapies in the treatment of non-small cell lung cancer].
2008 · Jacques De Grève, Lore Decoster, et al. · PubMed · 6
Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).
2012 · Pascal Wolter, Tine Hendrickx, et al. · Journal of Clinical Oncology · 5
Contaminants Within Bacterial Plasmid Preparations Trigger Apoptosis in Liposome Transfected Ovcar3, but Not in Skov3 or Az224 Human Ovarian Cancer Cells
2001 · Bart Neyns, Martine De Rijcke, et al. · Cell Biology International · 5
Preoperative (preop) chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (CC): Interim analysis of the PEPITA study.
2014 · Alain Hendlisz, Amélie Deleporte, et al. · Journal of Clinical Oncology · 3
A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver
2004 · Bart Neyns, Yves Van Nieuwenhove, et al. · Ghent University Academic Bibliography (Ghent University) · 3
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.
2019 · Alain Hendlisz, Rafael Caparica, et al. · Journal of Clinical Oncology · 2
First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (pts) (NCT00339586)—FIELT study group.
2011 · J. De Greve, J. P. Van Meerbeeck, et al. · Journal of Clinical Oncology · 2
P3-079: Prospective evaluation of first-line tyrosine kinase inhibition with erlotinib in patients with advanced non-small cell lung cancer (NSCLC) harbouring a mutant EGFR gene (FIELT study)
2007 · Jacques L. De Gréve, Jan Van Meerbeeck, et al. · Journal of Thoracic Oncology · 2
Restoration of an impaired TGF-beta1 autocrine growth-inhibitory circuit results in growth inhibition of ovarian epithelial cancer cells and complete inhibition of their tumorigenicity
2003 · Ziad Zeinoun, Erik Teugels, et al. · Cancer Detection and Prevention · 2
Characterization of Permanent Cell Lines That Contain the AAV2 rep-cap Genes on an Epstein-Barr-Virus-Based Episomal Plasmid
2001 · Bart Neyns, Joanna Vermeij, et al. · Intervirology · 2
Abstract P4-01-04: Adaptation of the EORTC Quality of Life Breast Cancer Module for male Breast Cancer – Results of the Phase I-II module
2025 · Vesna Bjelic-Radisic, Fatima Cardoso, et al. · Clinical Cancer Research · 1
True
2001 · Vermeij, J, Zeinoun, Z, et al. · British Journal of Cancer · 1
PDF
Works count: 47
Citation count: 912
H-index: 11
I10-index: 13
Year
Topic
Type